Insight Pharmaceuticals Acquires the MONISTAT® Business in U.S. and Canada  
8/30/2011 10:47:58 AM

LANGHORNE, Pa.--(BUSINESS WIRE)--Insight Pharmaceuticals, a portfolio company of Swander Pace Capital, announced today that it has acquired the MONISTAT® North American brand portfolio from McNEIL-PPC, Inc. The leading brand in the vaginal antifungal category, MONISTAT® joins Insight Pharmaceuticals’ family of over-the-counter (OTC) women’s health and personal care products which include leading brands such as e.p.t®, Nix®, Bonine®, and Sucrets®.